Is XRAY Stock Undervalued?
Dentsply Sirona (NASDAQ:XRAY) is a large manufacturer of dental equipment…
Buy
61
FOLD Quote, Financials, Valuation and Earnings
Last price:
$7.71
Seasonality move
:
-3.8%
Day range:
$7.56 - $7.75
52-week range:
$5.51 - $12.65
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
4.05x
P/B ratio:
11.45x
Volume:
4.2M
Avg. volume:
4.1M
1-year change:
-32.83%
Market cap:
$2.3B
Revenue:
$528.3M
EPS (TTM):
-$0.12
Earnings Data
Next earnings date for FOLD
Nov 05
2025
Most recent earnings per share
-$0.08
Missed by $0.10
(Jul 31/2025)
Consensus Estimate
$0.02
(Jul 31/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
FOLD Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 11/05/2025 | Q3 | $165.2M | -- | -- | $0.12 | -- |
| 07/31/2025 | Q2 | $146.7M | $154.7M | -$0.08 | $0.02 | -$0.10 |
| 05/01/2025 | Q1 | $136.3M | $125.2M | -$0.07 | $0.08 | -$0.15 |
| 02/19/2025 | Q4 | $147.9M | $149.7M | $0.05 | $0.09 | -$0.04 |
| 11/06/2024 | Q3 | $135M | $141.5M | -$0.02 | $0.05 | -$0.07 |
| 08/08/2024 | Q2 | $121.2M | $126.7M | -$0.05 | $0.02 | -$0.07 |
| 05/09/2024 | Q1 | $111.2M | $110.4M | -$0.16 | -$0.03 | -$0.13 |
| 02/28/2024 | Q4 | $115M | $115.1M | -$0.11 | -$0.04 | -$0.07 |
| 11/08/2023 | Q3 | -- | -- | -$0.07 | -$0.08 | $0.01 |
| 08/08/2023 | Q2 | -- | -- | -$0.15 | -$0.11 | -$0.04 |
| 05/10/2023 | Q1 | -- | -- | -$0.18 | -$0.14 | -$0.04 |
| 03/01/2023 | Q4 | -- | -- | -$0.19 | -$0.14 | -$0.05 |
| 11/07/2022 | Q3 | -- | -- | -$0.12 | -$0.19 | $0.07 |
| 08/04/2022 | Q2 | -- | -- | -$0.21 | -$0.22 | $0.01 |
| 05/09/2022 | Q1 | -- | -- | -$0.30 | -$0.29 | -$0.01 |
| 02/24/2022 | Q4 | -- | -- | -$0.29 | -$0.16 | -$0.13 |
| 11/09/2021 | Q3 | -- | -- | -$0.19 | -$0.18 | -$0.01 |
| 08/05/2021 | Q2 | -- | -- | -$0.19 | -$0.20 | $0.01 |
| 05/10/2021 | Q1 | -- | -- | -$0.25 | -$0.26 | $0.01 |
| 03/01/2021 | Q4 | -- | -- | -$0.27 | -$0.22 | -$0.06 |
| 11/05/2020 | Q3 | -- | -- | -$0.25 | -$0.20 | -$0.05 |
| 08/10/2020 | Q2 | -- | -- | -$0.20 | -$0.26 | $0.06 |
| 05/07/2020 | Q1 | -- | -- | -$0.35 | -$0.25 | -$0.10 |
| 03/02/2020 | Q4 | -- | -- | -$0.35 | -$0.26 | -$0.09 |
| 11/11/2019 | Q3 | -- | -- | -$0.24 | -$0.32 | $0.08 |
| 08/08/2019 | Q2 | -- | -- | -$0.36 | -$0.34 | -$0.03 |
| 05/08/2019 | Q1 | -- | -- | -$0.56 | -$0.31 | -$0.25 |
| 02/28/2019 | Q4 | -- | -- | -$0.41 | -- | -- |
| 11/05/2018 | Q3 | -- | -- | -$0.84 | -- | -- |
| 08/07/2018 | Q2 | -- | -- | -$0.33 | -- | -- |
| 05/08/2018 | Q1 | -- | -- | -$0.28 | -- | -- |
| 02/28/2018 | Q4 | -- | -- | -$0.41 | -- | -- |
| 11/08/2017 | Q3 | -- | -- | -$0.69 | -- | -- |
| 08/07/2017 | Q2 | -- | -- | -$0.34 | -- | -- |
| 05/09/2017 | Q1 | -- | -- | -$0.39 | -- | -- |
| 03/01/2017 | Q4 | -- | -- | -$0.42 | -- | -- |
| 11/07/2016 | Q3 | -- | -- | -$0.33 | -- | -- |
| 08/09/2016 | Q2 | -- | -- | -$0.40 | -- | -- |
| 05/03/2016 | Q1 | -- | -- | -$0.35 | -- | -- |
| 02/26/2016 | Q4 | -- | -- | -$0.35 | -- | -- |
| 11/03/2015 | Q3 | -- | -- | -$0.32 | -- | -- |
Amicus Therapeutics, Inc. Earnings Questions
-
How Much did Amicus Therapeutics, Inc. Generate in Revenue Last Quarter?
Amicus Therapeutics, Inc. reported $154.7M worth of top line sales in its most recent quarter.
-
Did Amicus Therapeutics, Inc. Beat Earnings Last Quarter?
Amicus Therapeutics, Inc. announced earnings per share of -$0.08 which represents a miss of analyst forecast a $0.02 per share.
-
Is Amicus Therapeutics, Inc. Profitable?
Amicus Therapeutics, Inc. reported $137.6M that represents $0.45 per share over the last quarter.
-
What is the Analyst Consensus for Amicus Therapeutics, Inc. EPS Next Year?
Amicus Therapeutics, Inc.'s earnings are forecast to decrease from -$0.18 per share to $0.24 per share next year representing a decrease of -50.71%.
-
When is Amicus Therapeutics, Inc.'s Earnings Date?
Amicus Therapeutics, Inc.'s next earnings date is November 5, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Clarivate Stock Undervalued?
Clarivate (NYSE:CLVT) is an analytics and research business whose services…
Is Dick’s Sporting Goods Stock Undervalued?
The market still prices Dick’s Sporting Goods (NYSE: DKS) at…
Stock Ideas
Buy
61
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 37x
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 38x
Alerts
Sell
30
MRVL alert for Sep 2
Marvell Technology, Inc. [MRVL] is up 1.25% over the past day.
Buy
62
ZEPP alert for Sep 2
Zepp Health Corp. [ZEPP] is up 2.84% over the past day.
Buy
78
AMBA alert for Sep 2
Ambarella, Inc. [AMBA] is down 5.15% over the past day.
